|
Left Ventricular Assist Device as permanent support in patients with end-stage heart failure |
Karason K, Dellgren G, Isaksson E, Lidén H, Liljegren A, Redfors B, Sjögren P, Svanberg T, Samuelsson O |
|
|
Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Karason K, Dellgren G, Isaksson E, Lidén H, Liljegren A, Redfors B, Sjögren P, Svanberg T, Samuelsson O. Left Ventricular Assist Device as permanent support in patients with end-stage heart failure. Gothenburg: The Regional Health Technology Assessment Centre (HTA-centrum). HTA-rapport 2014:66. 2014 Authors' conclusions Treatment with left ventricular assist device (LVAD) as destination therapy (DT) increases survival in patients with terminal heart failure. It is costly and hampered by several serious complications. During the last decade costs have come down and the rate of complications have started to decline. Indexing Status Subject indexing assigned by CRD MeSH Heart Failure; Heart-Assist Devices; Humans; Orthotic Devices; Ventricular Dysfunction, Left Language Published English Country of organisation Sweden English summary An English language summary is available. Address for correspondence The Regional Health Technology Assessment Centre, Region Vastra Gotaland, HTA-centrum, Roda Straket 8, Sahlgrenska Universitetssjukhuset, 413 45 GOTHENBORG, Sweden Email: hta-centrum@vgregion.se AccessionNumber 32016000586 Date abstract record published 29/03/2016 |
|
|
|